Saturday, December 06, 2025 | 08:50 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

EU negotiating with drugmakers to secure potential Covid-19 vaccines

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine

covid, coronavirus, vaccine, drug, pharma
premium

The multiple talks confirm the bloc's more assertive stance on procuring potential Covid-19 shots and drugs after early US moves in securing promising treatments and vaccines

Reuters Brussels
The European Union is negotiating advance purchase deals of potential Covid-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac, two EU sources told Reuters.

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine, in principle available to all 27 EU nations.

The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday, the sources said.

The